Biogen (BIIB) Change in Taxes (2014 - 2026)
Biogen (BIIB) posted quarterly Change in Taxes of $13.8 million for Q2 2026, up 102.29% year-over-year from $6.8 million in Q2 2025, and down 25.0% quarter-over-quarter from $18.4 million in Q1 2026.
Biogen (BIIB) Change in Taxes (2014 - 2026) Analysis & Trends
Biogen's Change in Taxes history runs 13 years deep, the most recent figure standing at $13.8 million for Q2 2026.
- In Q2 2026, Change in Taxes rose 102.29% year-over-year to $13.8 million; the TTM figure through Jun 2026 stood at -$391.2 million (up 12.78% YoY), while the FY2025 annual figure was -$958.1 million, down 1320.51% from the prior year.
- Change in Taxes for Q2 2026 stood at $13.8 million, down from $18.4 million in the prior quarter.
- The five-year high for Change in Taxes was $101.9 million in Q1 2022, with the low at -$603.8 million in Q2 2025.
- The 5-year median for Change in Taxes is -$19.0 million (2023), against an average of -$71.6 million.
- Peak annual rise in Change in Taxes reached 3240.91% in 2025, while the deepest fall reached 10878.18% in 2025.
- Biogen's Change in Taxes stood at -$42.1 million in 2022, then slumped by 337.53% to -$184.2 million in 2023, then jumped by 108.9% to $16.4 million in 2024, then plunged by 1282.93% to -$194.0 million in 2025, then jumped by 107.11% to $13.8 million in 2026.
- Business Quant data shows BIIB's Change in Taxes at $13.8 million in Q2 2026, $18.4 million in Q1 2026, and -$194.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | - |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | -2.22 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | - |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | -131.00 Mn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 171.00 Mn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | - |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Biogen | 32.04 Bn | 30.76 Bn | 1.96 Bn | 13.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.80 Mn |
| Jun 30, 2026 | 13.80 Mn |
| Mar 31, 2026 | 18.40 Mn |
| Mar 31, 2026 | 18.40 Mn |
| Dec 31, 2025 | -194.00 Mn |
| Dec 31, 2025 | -194.00 Mn |
| Sep 30, 2025 | -229.40 Mn |
| Sep 30, 2025 | -229.40 Mn |
| Jun 30, 2025 | -603.80 Mn |
| Jun 30, 2025 | -603.80 Mn |
| Mar 31, 2025 | 69.10 Mn |
| Mar 31, 2025 | 69.10 Mn |
| Dec 31, 2024 | 16.40 Mn |
| Dec 31, 2024 | 16.40 Mn |
| Sep 30, 2024 | 69.80 Mn |
| Sep 30, 2024 | 69.80 Mn |
| Jun 30, 2024 | -5.50 Mn |
| Jun 30, 2024 | -5.50 Mn |
| Mar 31, 2024 | -2.20 Mn |
| Mar 31, 2024 | -2.20 Mn |